Taking this into consideration as well as the fact that, as mentioned earlier, IL-6 regulates Th17/Treg balance, it is suggested that HMGB1 contributes to inhibition of the Treg activity and the exacerbation of the autoimmune inflammation in NMO patients [144]. Here, HMGB1 is linked to neuromyelitis optica.